TY  - GEN
AU  - Domchek,Susan M
AU  - Aghajanian,Carol
AU  - Shapira-Frommer,Ronnie
AU  - Schmutzler,Rita K
AU  - Audeh,M William
AU  - Friedlander,Michael
AU  - Balmaña,Judith
AU  - Mitchell,Gillian
AU  - Fried,Georgeta
AU  - Stemmer,Salomon M
AU  - Hubert,Ayala
AU  - Rosengarten,Ora
AU  - Loman,Niklas
AU  - Robertson,Jane D
AU  - Mann,Helen
AU  - Kaufman,Bella
TI  - Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy
SN  - 1095-6859
PY  - 2016///0601
KW  - Aged
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Genes, BRCA1
KW  - Genes, BRCA2
KW  - Germ-Line Mutation
KW  - Humans
KW  - Middle Aged
KW  - Organoplatinum Compounds
KW  - pharmacology
KW  - Ovarian Neoplasms
KW  - drug therapy
KW  - Phthalazines
KW  - adverse effects
KW  - Piperazines
KW  - Poly(ADP-ribose) Polymerase Inhibitors
KW  - Prospective Studies
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ygyno.2015.12.020
ER  -